Part D Coverage Gap Discount Relief Misses Ride On Opioids Bill

Biopharma will continue to seek ways to pass legislation reducing the 70% discount in Medicare Part D coverage gap but it looks like industry's next chance will be after the November elections.

More from Pricing Debate

More from Market Access